Indeed, a monoclonal antibody directed against ACE2 blocks viral infection in permissive cells3, whereas exogenous expression of human ACE2 allows SARS-CoV infection in non-human cells4. This evidence concerns the gene ACE2 and severe acute respiratory syndrome.